title: Absolute lymphocyte count as a predictive factor for response to monoclonal anti-CD20 antibody therapy.
authors.forename: D
authors.initials: D
authors.lastname: Decaudin
authors.forename: G
authors.initials: G
authors.lastname: Des Guetz
authors.forename: C
authors.initials: C
authors.lastname: Mathiot
authors.forename: J
authors.initials: J
authors.lastname: Dumont
authors.forename: P
authors.initials: P
authors.lastname: Hubert
authors.forename: A
authors.initials: A
authors.lastname: Vincent-Salomon
authors.forename: P
authors.initials: P
authors.lastname: Pouillart
mesh_terms: D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000627:therapeutic use*; D018951:Antigens, CD20 / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D018655:Lymphocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology* / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D014018:Tissue Distribution
chemical_list: D000911:Antibodies, Monoclonal; D018951:Antigens, CD20